echoloc
Get started
echoloc/ Companies/ Capricor Therapeutics, Inc.
Company profile

Capricor Therapeutics, Inc. Tech Stack

Cell and exosome therapeutics developer preparing for commercial launch

Biotechnology Research San Diego, CA - California 51–200 employees Founded 2005 Public Company
capricor.com LinkedIn

Capricor is a San Diego biotech developing cell and exosome-based biologics, led by a Duchenne muscular dystrophy cell therapy. Its hiring signals point to commercial readiness: accelerating roles in ops, manufacturing, quality and patient services, plus post-market surveillance, recall readiness and CAPA work, all typical of a company moving from clinic to market. A NetSuite, Veeva Vault and LIMS core supports SOX-governed finance and regulated quality operations.

Tech Stack 29 technologies

Core StackNetSuite Active Directory VMware Hyper-V AWS Intune Palo Alto Networks Smartsheet Salesforce Databricks Snowflake Tableau Power BI LIMS Veeva Vault ERP Azure Veeam SolarWinds PowerShell Veeva CrowdStrike Falcon Abnormal Security Rapid7 InsightVM KnowBe4 Adobe Acrobat Visio SuiteScript qPCR

What Capricor Therapeutics, Inc. Is BuildingChallenges and projects from their job posts

◆Challenges

  • Post-market quality and regulatory compliance
  • Ensuring SOX compliance
  • Inventory demands and production timelines
  • Building a medical affairs function
  • Ensuring assay reliability
  • Vendor oversight for complaint handling

▲Active Projects

  • Patient services infrastructure development
  • Post-market surveillance and data analysis
  • Recall readiness exercises
  • CAPA implementation
  • Investigator-initiated studies and real-world evidence
  • New animal models and preclinical imaging studies

Hiring Activity

Accelerating15 roles · 10 in 30d

Department

Ops
4
Healthcare
2
Manufacturing
2
Engineering
1
Logistics
1
Product
1
Quality
1
Research
1

Seniority

Senior
6
Mid
3
Director
2
Junior
2
Manager
1
Companies like Capricor Therapeutics, Inc.

200+ Biotechnology Research companies running NetSuite

See the full list

About Capricor Therapeutics, Inc.

Capricor Therapeutics is a publicly traded biotechnology company headquartered in San Diego, California, founded in 2005. It develops biologics built on cell and exosome technologies for serious diseases, with a lead cell therapy targeting Duchenne muscular dystrophy. Its exosome program engineers extracellular vesicles for conditions with high unmet need. The company employs 51–200 people and hires in the United States across operations, manufacturing, quality, research and medical functions.

HeadquartersSan Diego, CA - California
Company Size51–200 employees
Founded2005
Hiring MarketsUnited States

Frequently Asked Questions

What tech stack does Capricor Therapeutics use?

Capricor runs NetSuite with SuiteScript for ERP, Veeva Vault and LIMS for regulated content and lab data, Salesforce, Databricks, Snowflake, Tableau and Power BI, on AWS and Azure with CrowdStrike Falcon and Palo Alto Networks security.

Is Capricor Therapeutics hiring?

Yes. Hiring is accelerating, concentrated in operations, manufacturing, quality, healthcare and research roles in the United States, with a tilt toward senior and director-level hires.

What is Capricor Therapeutics working on?

Current work includes investigator-initiated studies, patient services infrastructure, post-market surveillance and data analysis, CAPA implementation, recall readiness exercises, and preclinical work on new animal models and imaging.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

G
Geneoscopy
Biotechnology Research
P
Praxis Precision Medicines, Inc.
Biotechnology Research
A
Ardelyx, Inc.
Biotechnology Research
S
SystImmune
Biotechnology Research

How this profile is built

Capricor Therapeutics, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.